Cargando…
Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis
p16, encoded by the CDKN2A gene, is a tumor suppressor that has been widely studied in cancer research. However, the relationship of p16 with prognostic and clinicopathological parameters in patients with bladder cancer remains unclear. Data inclusion criteria were articles reporting on the relation...
Autores principales: | Gan, Xiaoning, Lin, Xiaomiao, He, Rongquan, Lin, Xinggu, Wang, Hanlin, Yan, Liyan, Zhou, Hong, Qin, Hui, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854991/ https://www.ncbi.nlm.nih.gov/pubmed/27199504 http://dx.doi.org/10.1155/2016/5259602 |
Ejemplares similares
-
Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis
por: Jiang, Mengtong, et al.
Publicado: (2016) -
The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer
por: Li, Jinze, et al.
Publicado: (2022) -
Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues
por: Rong, Minhua, et al.
Publicado: (2014) -
Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
por: Zhu, Lei, et al.
Publicado: (2019) -
Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance
por: Wang, Lingling, et al.
Publicado: (2016)